The Risk and Outcomes of Pneumonia in Patients on Inhaled Corticosteroids

Pulmonary Pharmacology and Therapeutics - United States
doi 10.1016/j.pupt.2015.04.001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Observational Study of Inhaled Corticosteroids on Outcomes for COPD Patients With Pneumonia

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2011English

Pneumonia Risk in COPD Patients Receiving Inhaled Corticosteroids Alone or in Combination: TORCH Study Results

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2009English

Inhaled Corticosteroids in COPD and the Risk of Lung Cancer

International Journal of Cancer
Cancer ResearchOncology
2018English

Trends in Sales of Inhaled Corticosteroids and Asthma Outcomes in Singapore

Thorax
PulmonaryRespiratory Medicine
2006English

Inhaled Corticosteroids

Pharmaceuticals
Molecular MedicinePharmaceutical Science
2010English

Withdrawal of Inhaled Corticosteroids in COPD Patients: Rationale and Algorithms

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2019English

Investigation of Mouth Washing After Inhaled Corticosteroids in the Patients

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2005English

The Effects of Inhaled Corticosteroids on Bone Mineral Density in Male Patients With Bronchial Asthma

Journal of the Royal Medical Services
2014English

Adjunctive Corticosteroids Decreased the Risk of Mortality of Non-Hiv Pneumocystis Pneumonia

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy